Search - tctmd.com

Displaying 1 - 16 of 16

Sort: Relevancy | Date

News Opinion CV Team Dispatch

July 2023 News Roundup

L.A. McKeown

July 01, 2023

News Conference News STS 2023

Surgeons Argue: STS Data Again Show ISCHEMIA Isn’t Definitive for CABG

Yael L. Maxwell

January 30, 2023

News Opinion CV Team Dispatch

June 2022 News Roundup

L.A. McKeown

June 01, 2022

News Conference News STS 2022

Bicuspid SAVR Outcomes Meet or Beat Tricuspid in STS Database

L.A. McKeown

February 02, 2022

News Daily News

Post-MI Mechanical Complications Infrequent but Deadly

Todd Neale

September 16, 2019

News Conference News STS 2019

TAVR Outcomes Dependent on SAVR Hospital Volumes

Yael L. Maxwell

January 28, 2019

News Conference News ESC 2018

ESC 2018: Trimming DAPT, New NOAC Niches, Aspirin Scrutiny for Primary Prevention, and More

Shelley Wood

August 20, 2018

News Industry News

Essential Medical Announces Positive Results from The Safe Manta Clinical Trial, The First Pivotal Trial for a Dedicated Large Bore Closure Device

June 25, 2018

Presentation CHIP at ACC 2018

Impella Assisted BAV

Presenter: Duane S. Pinto

March 09, 2018

Presentation JIM 2018

Case: Immediately after PCI and BAV the patient was given aspirin 250 mg iv and Plavix 300 mg

Presenter: Ferdinando Varbella

February 23, 2018

News Daily News

ICTUS: No Benefit at 10 Years With Early Invasive Strategy in NSTE ACS Patients

Michael O'Riordan

April 11, 2017

News Daily News

Another Meta-Analysis Supports Prolonged Bivalirudin Use in STEMI, but Is Contemporary PCI Reflected?

Yael L. Maxwell

July 27, 2016

News Industry News

Essential Medical Inc. Announces Successful Completion of EU Clinical Studies for MANTA™ Large Bore Vascular Closure Device

January 31, 2016

News Industry News

Essential Medical Inc. Announces Successful Commencement of EU Studies for MANTA™ Large Bore Vascular Closure Device

July 27, 2015

News Daily News

Risk Peaks Early After Clopidogrel Cessation in SVG PCI Patients

November 13, 2012

Presentation TCT 2012

The Association Between Duration of Clopidogrel Therapy After Saphenous Vein Graft Intervention And Long-Term Death And Myocardial Infarction

Presenter: Amit Sachdeva, Sumati Bavisetty, Gerald Beckham, Vicken Aharonian, Prakash Mansukhani, Gregg W. Stone, Naing Moore, Ric Hyett, Richard Contreras, Somjot S. Brar

January 03, 2012

Advertisement

July 2023 News Roundup

Surgeons Argue: STS Data Again Show ISCHEMIA Isn’t Definitive for CABG

June 2022 News Roundup

Bicuspid SAVR Outcomes Meet or Beat Tricuspid in STS Database

Post-MI Mechanical Complications Infrequent but Deadly

TAVR Outcomes Dependent on SAVR Hospital Volumes

ESC 2018: Trimming DAPT, New NOAC Niches, Aspirin Scrutiny for Primary Prevention, and More

Essential Medical Announces Positive Results from The Safe Manta Clinical Trial, The First Pivotal Trial for a Dedicated Large Bore Closure Device

Impella Assisted BAV

Case: Immediately after PCI and BAV the patient was given aspirin 250 mg iv and Plavix 300 mg

ICTUS: No Benefit at 10 Years With Early Invasive Strategy in NSTE ACS Patients

Another Meta-Analysis Supports Prolonged Bivalirudin Use in STEMI, but Is Contemporary PCI Reflected?

Essential Medical Inc. Announces Successful Completion of EU Clinical Studies for MANTA™ Large Bore Vascular Closure Device

Essential Medical Inc. Announces Successful Commencement of EU Studies for MANTA™ Large Bore Vascular Closure Device

Risk Peaks Early After Clopidogrel Cessation in SVG PCI Patients

The Association Between Duration of Clopidogrel Therapy After Saphenous Vein Graft Intervention And Long-Term Death And Myocardial Infarction

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content